Active, not recruitingNCT03278119

Sleep Aging and Risk for Alzheimer's 2.0

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
NYU Langone Health
Principal Investigator
Ricardo Osorio, MD
New York Langone Medical Center
Intervention
PET Scan and nocturnal polysomnography(diagnostic_test)
Enrollment
158 target
Eligibility
55-75 years · All sexes
Timeline
2018 – 2026

Study locations (1)

Collaborators

National Institute on Aging (NIA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03278119 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials